Henk Solleveld is a Preclinical Pharmaceutical Executive with over 20 years of experience in the Discovery and Development arenas within the pharmaceutical industry. His experience cuts across every facet of the R & D process. He has led pathology and toxicology groups, discovery DMPK and liaised in the discovery organization with all preclinical departments, viz., safety assessment, development DMPK and chemical and pharmaceutical development.
Experience
2000 - 2008: Transnational Vice-President and Head, Preclinical Drug Discovery, Cardiovascular/Urogenital Center of Excellence Drug Discovery, GSK 1998 -2000: Transnational Group Director, Investigative Pathology & Regulatory Toxicology, SmithKline Beecham
